Invention Grant
- Patent Title: Methods of treating FGF21-associated disorders
-
Application No.: US17539335Application Date: 2021-12-01
-
Publication No.: US11802152B2Publication Date: 2023-10-31
- Inventor: Brian Boettcher , Shari Lynn Caplan , Regis Cebe , Guochun Li , John A. Taraszka , Fangmin Xu , David Langdon Yowe
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Morgan, Lewis & Bockius LLP
- The original application number of the division: US15749775
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P3/00 ; A61K39/00
Abstract:
The present invention relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human β-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
Public/Granted literature
- US20220162300A1 METHODS OF TREATING FGF21-ASSOCIATED DISORDERS Public/Granted day:2022-05-26
Information query
